163 related articles for article (PubMed ID: 8409781)
21. [Clinical study of platelet activation in cerebral circulation--comparison between ischemic stroke subtypes and Binswanger's disease].
Iwamoto T; Kubo H; Takasaki M
Rinsho Shinkeigaku; 1994 Aug; 34(8):793-8. PubMed ID: 7994986
[TBL] [Abstract][Full Text] [Related]
22. [Plasma homocysteine levels in patients with ischemic cerebral infarction].
Vila N; Deulofeu R; Chamorro A; Piera C
Med Clin (Barc); 1998 May; 110(16):605-8. PubMed ID: 9656197
[TBL] [Abstract][Full Text] [Related]
23. Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits.
Chang CY; Chen JY; Ke D; Hu ML
Nutrition; 2005 Oct; 21(10):987-93. PubMed ID: 16157235
[TBL] [Abstract][Full Text] [Related]
24. [Hemo-rheologic disorders as risk factors of ischemic cerebral infarction].
Kowal P
Neurol Neurochir Pol; 1991; 25(6):737-43. PubMed ID: 1811179
[TBL] [Abstract][Full Text] [Related]
25. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
Salobir B; Sabovic M; Zupan IP; Ponikvar JB
Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
[TBL] [Abstract][Full Text] [Related]
26. [Flow cytometric 3-color analysis of circulating activated platelets and its clinical significance in ischemic cerebrovascular diseases].
Wang J; Cao L; He M
Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):499-502. PubMed ID: 11798806
[TBL] [Abstract][Full Text] [Related]
27. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
[TBL] [Abstract][Full Text] [Related]
28. [Blood rheology and fibrinogenemia: two independent parameters in the assessment of cerebral vascular damage].
Cortinovis A; Crippa A; Crippa M
Minerva Med; 1995 Dec; 86(12):511-8. PubMed ID: 8684676
[TBL] [Abstract][Full Text] [Related]
29. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
30. Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack.
McCabe DJ; Harrison P; Sidhu PS; Brown MM; Machin SJ
Br J Haematol; 2004 Sep; 126(6):861-9. PubMed ID: 15352991
[TBL] [Abstract][Full Text] [Related]
31. Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
Dempfle CE; Kälsch T; Elmas E; Suvajac N; Lücke T; Münch E; Borggrefe M
Blood Coagul Fibrinolysis; 2008 Dec; 19(8):765-70. PubMed ID: 19002042
[TBL] [Abstract][Full Text] [Related]
32. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
33. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
34. [Etiopathogenesis of acute myocardial infarction: role of early leukocytosis].
Zanini R; Curello S; Bonandi L; Giovannini G; Boldi E; D'Aloia A; Metra M; Nodari S; Dei Cas L
Cardiologia; 1998 Sep; 43(9):925-31. PubMed ID: 9859607
[TBL] [Abstract][Full Text] [Related]
35. beta-fibrinogen gene -455A/G polymorphism and plasma fibrinogen level in Chinese stroke patients.
Liu Y; Pan J; Wang S; Li X; Huang Y
Chin Med J (Engl); 2002 Feb; 115(2):214-6. PubMed ID: 11940334
[TBL] [Abstract][Full Text] [Related]
36. Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.
Thekkedath UR; Chirananthavat T; Leypoldt JK; Cheung AK; Mohammad SF
Am J Hematol; 2006 Dec; 81(12):915-26. PubMed ID: 16917914
[TBL] [Abstract][Full Text] [Related]
37. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia.
Lang T; Johanning K; Metzler H; Piepenbrock S; Solomon C; Rahe-Meyer N; Tanaka KA
Anesth Analg; 2009 Mar; 108(3):751-8. PubMed ID: 19224779
[TBL] [Abstract][Full Text] [Related]
38. Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke.
Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Wang HC; Lee TH; Lu CH
Thromb Res; 2009 Jun; 124(2):213-8. PubMed ID: 19233449
[TBL] [Abstract][Full Text] [Related]
39. Plasma thrombomodulin, fibrinogen, and activity of tissue factor as risk factors for acute cerebral infarction.
Zhang X; Hu Y; Hong M; Guo T; Wei W; Song S
Am J Clin Pathol; 2007 Aug; 128(2):287-92. PubMed ID: 17638664
[TBL] [Abstract][Full Text] [Related]
40. Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke.
Dai DF; Thajeb P; Tu CF; Chiang FT; Chen CH; Yang RB; Chen JJ
J Am Coll Cardiol; 2008 Jun; 51(22):2173-80. PubMed ID: 18510966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
